CRON (Cronos Group Inc.) Stock Financials & Earnings | Market Cap Arena

CRON (Cronos Group Inc.) Stock Financials & Earnings | Market Cap Arena

CRONCronos Group Inc.

Mkt Cap$983M

Healthcare·Drug Manufacturers - Specialty & Generic·🇨🇦 Canada·NASDAQ

Revenue (TTM)$193M

Net Income (TTM)-$9M

EPS (TTM)-$0.02

Free Cash Flow (TTM)$121,593

Gross Margin32.5%

Op. Margin-1.5%

Net Margin-4.9%

FCF Margin0.1%

P/S Ratio (TTM)5.1x

P/E Ratio (TTM)—

YoY Rev Growth+64.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$19M	$3M	-$21M
Q2 23	$19M	$3M	-$21M
Q3 23	$25M	$4M	-$22M
Q4 23	$24M	$2M	-$22M
Q1 24	$25M	$4M	-$16M
Q2 24	$28M	$6M	-$16M
Q3 24	$34M	$4M	-$34M
Q4 24	$30M	$11M	-$11M
Q1 25	$32M	$14M	-$4M
Q2 25	$33M	$15M	-$5M
Q3 25	$36M	$18M	-$503K
Q4 25	$91M	$16M	$7M

Valuation

Quarter	P/S	P/E
Q1 23	10.0x	—
Q2 23	11.0x	—
Q3 23	11.4x	—
Q4 23	11.3x	—
Q1 24	10.6x	—
Q2 24	9.7x	—
Q3 24	8.8x	—
Q4 24	8.4x	23.9x
Q1 25	7.9x	19.9x
Q2 25	7.5x	53.2x
Q3 25	7.4x	27.2x
Q4 25	5.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$48M	-$48M
Q2 23	-$12M	-$12M
Q3 23	-$183K	-$508K
Q4 23	$17M	$15M
Q1 24	-$2M	-$4M
Q2 24	$2M	$828K
Q3 24	$12M	$5M
Q4 24	$8M	$4M
Q1 25	-$2M	-$17M
Q2 25	$3M	-$1M
Q3 25	$13M	$9M
Q4 25	$12M	$10M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$804K
Q2 23	$502K
Q3 23	$325K
Q4 23	$2M
Q1 24	$2M
Q2 24	$916K
Q3 24	$7M
Q4 24	$4M
Q1 25	$15M
Q2 25	$4M
Q3 25	$5M
Q4 25	$2M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-31.3%	-40.9%
Q2 23	-31.6%	-34.3%
Q3 23	-12.0%	-29.4%
Q4 23	+4.5%	-23.4%
Q1 24	+29.7%	+2.4%
Q2 24	+46.0%	+9.3%
Q3 24	+38.1%	+45.8%
Q4 24	+26.7%	-8.5%
Q1 25	+27.6%	-11.9%
Q2 25	+20.5%	-10.5%
Q3 25	+6.1%	-45.8%
Q4 25	+201.3%	+102.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$3M	13.1%
Q2 23	$2M	12.3%
Q3 23	$2M	7.9%
Q4 23	$2M	8.1%
Q1 24	$2M	8.0%
Q2 24	$2M	8.1%
Q3 24	$2M	6.6%
Q4 24	$2M	7.2%
Q1 25	$2M	6.5%
Q2 25	$1M	4.1%
Q3 25	$2M	6.4%
Q4 25	-$6M	-6.4%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$2M	$14M	$6M
Q2 23	$1M	$16M	$5M
Q3 23	$1M	$16M	$5M
Q4 23	$1M	$12M	$6M
Q1 24	$997K	$11M	$5M
Q2 24	$962K	$15M	$4M
Q3 24	$1M	$15M	$6M
Q4 24	$1M	$14M	$6M
Q1 25	$793K	$11M	$5M
Q2 25	$929K	$12M	$5M
Q3 25	$1M	$12M	$5M
Q4 25	$1M	$7M	$7M

Revenue Segments

Quarter	Cannabis Extracts	Cannabis Flower	Product and Service, Other
Q1 23	$7M	$13M	$66K
Q2 23	$5M	$14M	$81K
Q3 23	$7M	$17M	$128K
Q4 23	$5M	$18M	$327K
Q1 24	$8M	$18M	$36K
Q1 25	$9M	$23M	$310K
Q2 25	$8M	$25M	$70K
Q3 25	$10M	$26M	$13K

Revenue by Geography

Quarter	Canada	Israel	United States	Other Countries
Q1 23	$14M	$5M	$649K	—
Q2 23	$14M	$5M	—	—
Q3 23	$19M	$6M	—	$399K
Q4 23	$18M	$5M	—	$1M
Q1 24	$19M	$6M	—	—
Q1 25	$20M	$9M	—	$3M
Q2 25	$19M	$9M	—	$5M
Q3 25	$23M	$11M	—	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$414M	$423M	$836M
Q2 23	$542M	$572M	$1.1B
Q3 23	$776M	$364M	$1.1B
Q4 23	$669M	$192M	$862M
Q1 24	$855M	$0	$855M
Q2 24	$848M	$0	$848M
Q3 24	$862M	$0	$862M
Q4 24	$859M	$0	$859M
Q1 25	$798M	$40M	$838M
Q2 25	$794M	$40M	$834M
Q3 25	$784M	$40M	$824M
Q4 25	$792M	$40M	$832M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	381M	+0.5%
Q2 23	381M	+0.1%
Q3 23	381M	+0.0%
Q4 23	381M	+0.0%
Q1 24	381M	+0.1%
Q2 24	382M	+0.2%
Q3 24	386M	+1.0%
Q4 24	387M	+0.1%
Q1 25	387M	+0.1%
Q2 25	385M	-0.4%
Q3 25	385M	+0.0%
Q4 25	385M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 20	$70K	665
FY 21	$103K	626
FY 22	$194K	447
FY 23	$245K	356
FY 24	$256K	459
FY 25	$317K	610